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ABSTRACT
The aim of this study was to identify and characterize the receptor system
involved in controlling encystment in Acanthamoeba using specific agonists
and antagonists and to examine whether endogenous stores of catecholami-
nes are produced by the organism. Acanthamoeba trophozoites suspended in
axenic growth medium were exposed to adrenoceptor agonists and antago-
nists to determine which compounds promoted or prevented encystment.
Second, trophozoites were cultured in medium containing a catecholamine
synthesis inhibitor to investigate the effect this had on natural encystment.
Nonspecific adrenoceptor agonists including epinephrine, isoprotenerol, and
the selective b1 adrenoceptor agonist dobutamine were found to cause
> 90% encystment of Acanthamoeba trophozoites compared to < 30% with
the controls. The selective b1 antagonist metoprolol was able to inhibit epi-
nephrine mediated encystment by > 55%. Cultures of Acanthamoeba with the
catecholamine synthesis inhibitor a-methyl-p-tyrosine significantly reduced the
level of amoebic encystment compared to controls. In conclusion, Acan-
thamoeba appear to contain a functional adrenergic receptor system of
unknown structure which is involved in initiating the encystment process that
can be activated and blocked by b1 agonists and antagonists respectively. Fur-
thermore, the presence of this receptor system in Acanthamoeba indicates
that topical b adrenoceptor blockers may be effective adjunct therapy by
reducing the transformation of trophozoites into the highly resistant cyst
stage.
ACANTHAMOEBA is a common environmental free-living
amoeba characterized by a life cycle of a feeding and repli-
cating trophozoite which, in response to adversity, can
transform into a highly resistant cyst stage (Byers et al.
1980; Cordingley et al. 1996). Acanthamoeba spp. are
opportunistic pathogens of humans, notably causing ker-
atitis in previously healthy persons. Contact lens wearers
are most at risk from Acanthamoeba keratitis and account
for some 90% of reported cases (Radford et al. 1998; Tu
2014).
Acanthamoeba keratitis is one of the most difficult ocu-
lar infections to manage successfully and can result in per-
manent blindness. Current medical therapy involves
topical administration of a biguanide (either polyhexam-
ethylene biguanide or chlorhexidine digluconate) in
combination with a diamidine compound (propamidine
isethinoate or hexamidine diisethionate) (Lorenzo-Morales
et al. 2015). Even with prompt diagnosis and aggressive
medical therapy, the mean treatment period can be over
5 mo and in approximately 5% of cases the condition fails
to respond to treatment (Dart et al. 2009). Many cases
require a penetrating keratoplasty to either control the
infection or resolve the damage caused by the organism
and inflammatory response (Dart et al. 2009). The pres-
ence of dormant cysts in the corneal tissue can lead to
recrudescence upon cessation of drug treatment causing
infection of the corneal graft in up to 41% of patients after
penetrating keratoplasty (Kitzmann et al. 2009).
A variety of chemical mediators including antibiotics,
ethidium bromide, cyclic adenosine monophosphate
(cAMP), taurine, and epinephrine have previously been
shown to induce encystment (Akins and Byers 1980;
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Raizada and Krishna Murti 1972; Srivastava and Shukla
1983b). In many eukaryotic cells cAMP-dependent sig-
nalling pathways play a critical role in regulating cell
growth, metabolism, and differentiation and the levels of
cAMP have been observed to increase in encysting
Acanthamoeba (Abel et al. 2001; Raizada and Krishna
Murti 1972). In mammalian systems, one mechanism for
elevating intracellular levels of cAMP is through the action
of the endogenous catecholamine epinephrine. In the liver
this results in increased glycogen phosphorylase activity
and the subsequent breakdown of the liver’s glycogen
stores (Riley and Haynes 1963). During encystment,
glycogen metabolism is one of the key processes that has
been observed in Acanthamoeba and it has been noted
that the activation of adenylate cyclase, leading to polymer
degradation, resembles the behaviour of the mammalian
liver or muscle in its response to epinephrine (Verma and
Murti 1976b; Weisman et al. 1970).
Furthermore, epinephrine and the synthetic cate-
cholamine isoprotenerol have been shown to directly
induce encystment in trophozoites of A. culbertsoni in the
presence of magnesium (Srivastava and Shukla 1983b).
Radio-labelled epinephrine has also been shown to be
taken up by Acanthamoeba in a process blocked by the b
adrenoceptor antagonist propranolol but not by the a
antagonist phentolamine (Verma and Murti 1976a). Conse-
quently, it has been suggested that the Acanthamoeba
which interact with epinephrine, show some resemblance
to the mammalian b adrenergic receptor in their sensitivity
to the b adrenoceptor (bAR) antagonist propranolol (Verma
and Murti 1976a).
Epinephrine has been reported to have been identified
spectrophotometrically within A. culbertsoni in an unpub-
lished observation (Verma et al. 1974) but conclusive evi-
dence has not been published to date. Very little is known
about exactly how Acanthamoeba senses and responds to
its changing environment and the receptors and chemical
pathways involved. However, previous studies with Enta-
moeba invadens have indicated that this organism con-
tains a functional adrenergic signalling system through
studies demonstrating the encystment promoting proper-
ties of catecholamines (Coppi et al. 2002) and through the
identification of a G-protein-regulated adenylate cyclase
that functions downstream from a adrenergic receptor
(Frederick and Eichinger 2004).
Acanthamoeba keratitis is one of the most difficult ocu-
lar infections to treat and drugs including the diamidine
compounds that are currently used in the treatment of
Acanthamoeba keratitis have been reported to induce the
encystment of Acanthamoeba at low concentrations by
interfering with Acanthamoeba polyamine metabolism
(Akins and Byers 1980; Ogbunude and Asiri 2001). There-
fore, a compound which is able to prevent the transforma-
tion of trophozoites into the highly resistant cyst stage
may prove to be useful tool for improving the treatment
of this infection.
The aim of this study was to identify and characterize
the receptor system involved in controlling encystment in
Acanthamoeba using specific agonists and antagonists.
This study will then determine if compounds related to
epinephrine are synthesized and released by Acan-
thamoeba. To this end, this study has addressed the
hypothesis that Acanthamoeba contains a functional
adrenergic signalling system which enables them produce
and store catecholamines that are released to initiate the
encystment process via an interaction with adrenoceptors
located on the surface of the trophozoite.
MATERIALS AND METHODS
Acanthamoeba strains and culture methods
Acanthamoeba castellanii (ATCC 30868) and A. culbertsoni
(ATCC 30171) were obtained from LGC Standards (Ted-
dington, UK). Acanthamoeba polyphaga (Ros) was isolated
from a case of keratitis in 1991 (Kilvington et al. 1990).
Acanthamoeba were cultured in 75 cm2 tissue culture
flasks (Nunc, Gloucester, UK) containing 30 ml of semi-
defined axenic Acanthamoeba growth medium at 30 °C as
previously described (Hughes et al. 2003). Acanthamoeba
castellanii was selected for the encystment studies over
A. culbertsoni and A. polyphaga because it has a more
favourable encystment profile in growth medium supple-
mented with 50 mM MgCl2 (Sigma, Gillingham, UK).
Through personal observations, A. culbertsoni does not
encyst in a nutrient encystment medium possibly through
the presence of catabolite repressors that oppose encyst-
ment (Srivastava and Shukla 1983a). Acanthamoeba poly-
phaga too readily encysted making it difficult to tell what
level of encystment was due to the exogenous cate-
cholamines and what was due to natural encystment.
Acanthamoeba castellanii was found to be in between
these two extremes and gave intermediate levels of natu-
ral encystment in growth medium supplemented with
50 mM MgCl2.
Adrenoceptor agonist/antagonist studies
Encystment studies were performed in 50 ml polypropy-
lene tubes containing 2.5 9 105/ml trophozoites in 5 ml
Acanthamoeba axenic growth medium. All adrenoceptor
agonists and antagonists were obtained from Sigma
(Gillingham, UK). The required concentrations of MgCl2
and a adrenoceptor (aAR) or b adrenoceptor (bAR) ago-
nists and antagonists were subsequently added and the
tubes were placed in an orbital shaking incubator at 30 °C
and 120 rpm. Each day over a 7 d period the percentage
encystment was recorded using a modified Fuchs Rosen-
thal haemocytometer (Hawksley, Lancing, UK).
Inhibition of catecholamine synthesis
Acanthamoeba polyphaga was selected for the inhibition
of catecholamine synthesis study over the other two
strains as it readily encysted in trophozoite growth med-
ium supplemented with 50 mM MgCl2 in the absence of
exogenous catecholamines. Two cultures of the
A. polyphaga strain were set up and passaged three times
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through either standard trophozoite growth medium or
trophozoite growth medium supplemented with 10 mM of
the catecholamine synthesis inhibitor a-methyl-p-tyrosine
(AMPT) (Sigma). The two cultures were then transferred
to trophozoite growth medium supplemented with 50 mM
MgCl2 to facilitate encystment.
Data analysis
Statistical analysis was performed using one-way analysis
of variance (ANOVA) of data from triplicate experiments
on the InStat statistical software package (GraphPad, La
Jolia, CA).
RESULTS
Adrenoceptor agonists
The results for the adrenoceptor agonist studies with
A. castellanii are shown in Table 1. A low level of encyst-
ment of Acanthamoeba occurred in standard growth med-
ium (GM) in the absence of Mg2+ compared to 32% upon
the addition of 50 mM MgCl2 (p > 0.05). Encystment was
further enhanced by the addition of epinephrine from 0.05,
to 0.5, and up to 5 mM giving encystment of 56%, 72%,
and 93% respectively (p < 0.001 for all relative to control).
Isoproterenol induced approximately 90% encystment of
A. castellanii (p < 0.001), whereas with norepinephrine only
45% encystment (p < 0.001). The selective bAR1 agonist
dobutamine gave encystment of 92% (p < 0.001) and the
selective bAR2 agonist salbutamol gave encystment of 39%
at 10 lM (p < 0.01). Salbutamol could not be tested at
higher concentrations as the compound caused extensive
lysis of the Acanthamoeba trophozoites. The aAR agonist
phenylephrine gave minimal encystment of approximately
10% at 100 lM (p > 0.05) and dibutyryl-cAMP, a lipophillic
form of cyclic adenosine monophosphate which can cross
intact membranes was also found to promote encystment
of > 70% (p < 0.001).
Adrenoceptor antagonists
The results for the adrenoceptor antagonist studies with
A. castellanii are shown in Table 2, Epinephrine was
added to the growth medium at a concentration of
500 lM along with 50 mM MgCl2 and 500 lM of the
antagonist to be tested. In the absence of antagonist,
0.5 mM epinephrine gave 72% encystment of A. castel-
lanii. When the aAR antagonist phentolamine was added
no decrease in the level of encystment was observed
(p > 0.05). With the two nonselective bAR antagonists’
alprenolol and propranolol the level of encystment
decreased to 39% and 44% respectively (p < 0.01 for
both). A small decrease of < 10% in encystment with the
selective bAR2 antagonist ICI-118,551 (p > 0.05) was
observed in contrast with the > 55% increase in the level
of encystment seen with the bAR1 antagonist metoprolol
(p < 0.001).
Inhibiting catecholamine synthesis using AMPT
The results for the catecholamine synthesis inhibitor stud-
ies with A. polyphaga are shown in Table 3, A. polyphaga
trophozoites grown in standard growth medium gave max-
imal encystment of 65% at 7 d compared to only 18%
with the trophozoites grown in the presence of AMPT
prior to encystment (p < 0.001).
DISCUSSION
The resistance of Acanthamoeba cysts to most antimicro-
bial agents at concentrations tolerated by the cornea
makes Acanthamoeba keratitis one of the most difficult
Table 1. The effect of adrenoceptor agonists and dibutyryl cyclic ade-
nosine monophosphate (cAMP) on the encystment of Acanthamoeba
castellanii 3
Encystment conditions
Agonist
target
% Encystment
( SEM)
GM None 8.0  0.7
GM + Mg2+ None 29.1  2.9
GM + Mg2+ + Epinephrine (5 mM) aAR/bAR 93.2  2.3
GM + Mg2++ Epinephrine (0.5 mM) aAR/bAR 75.3  3.5
GM + Mg2+ + Epinephrine (0.05 mM) aAR/bAR 56.0  7.2
GM + Mg2+ + Isoprotenerol (1 mM) aAR/bAR 92.0  2.3
GM + Mg2+ + Norepinephrine (5 mM) aAR/bAR 41.5  4.0
GM + Mg2+ + Phenylephrine (100 lM) aAR 9.5  1.7
GM + Mg2+ + Dobutamine (100 lM) bAR1 92.4  2.0
GM + Mg2+ + Salbutamol (10 lM) bAR2 38.8  3.8
GM + Mg2+ + Dibutyryl-cAMP
(100 lM)
Increases
cAMP
72.6  9.0
aThe values reported are  the standard error of the mean from tripli-
cate experiments.
bGM (Growth media), Mg2+ (50 mM MgCl2), aAR/bAR (beta/alpha
adrenoceptor).
Table 2. The effect of adrenoceptor antagonists on the epinephrine
mediated encystment of Acanthamoeba castellanii
Encystment conditions
Antagonist
target
% Encystment
( SEM)
GM + Mg2+ + Epinephrine
(500 lM)
None 75.3  3.5
GM + Mg2+ + Epinephrine
(500 lM) + Phentolamine (500 lM)
aAR 74.0  6.4
GM + Mg2+ + Epinephrine
(500 lM) + Alprenolol (500 lM)
bAR 36.0  3.1
GM + Mg2+ + Epinephrine
(500 lM) + Propranolol (500 lM)
bAR 40.7  5.7
GM + Mg2+ + Epinephrine
(500 lM) + Metoprolol (500 lM)
bAR1 18.8  2.0
GM + Mg2+ + Epinephrine
(500 lM) + ICI 118,551 (500 lM)
bAR2 59.7  6.5
aThe values reported are  the standard error of the mean from tripli-
cate experiments.
bGM (Growth media), Mg2+ (50 mM MgCl2), aAR/bAR (beta/alpha
adrenoceptor).
© 2016 The Author(s) Journal of Eukaryotic Microbiology © 2016 International Society of Protistologists
Journal of Eukaryotic Microbiology 2016, 0, 1–6 3
Heaselgrave & Kilvington Adrenergic Signalling in Acanthamoeba
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
ocular infections to manage and requires intensive and
prolonged medical therapy (Duguid et al. 1997; Elder et al.
1994; Marciano-Cabral and Cabral 2003). Gaining greater
understanding of the mechanism behind the process by
which the trophozoite transforms into the highly resistant
stage will enable us to develop strategies for preventing
encystation in vivo which will in turn reduce treatment
time and prevent recrudescence of infection.
The nonspecific adrenoceptor agonists’ epinephrine and
isoprotenerol showed strong encystment promoting activity
in Acanthamoeba. The maximal encystment obtained with
norepinephrine another nonspecific adrenoceptor agonist
was approximately 50% lower, suggesting it was only hav-
ing partial agonist activity. When using the specific adreno-
ceptor agonists we found that aAR agonist phenylephrine
had no encystment promoting activity, whereas selective
bAR1 agonist produced maximal encystment equivalent to
epinephrine albeit at a 50 fold lower concentration. This
result suggest that the type of adrenoceptor found in Acan-
thamoeba is of the bAR1 subtype but the issue is confused
by the observation that salbutamol a specific bAR2 agonist
exhibited partial agonist activity producing encystment at a
level that was 50% of that seen with dobutamine. The exact
reason for salbutamol and norepinephrine acting as partial
agonists when we would expect salbutamol to have no
effect, and norepinephrine to be equipotent with epinephr-
ine is unclear. However, we must remember that adreno-
ceptor classification was developed in mammalian systems
and we are trying to apply this categorization to a single
celled amoeba. It is possible that we are looking an evolu-
tionary primitive form of the receptor to that which we see
in mammals and any structural differences may mean ago-
nists behave differently to what is expected. Furthermore,
the epinephrine concentrations used in this study were simi-
lar to those used in a previous study with Entamoeba spp.
but these are significantly higher than those expected physi-
ologically (Coppi et al. 2002). The difference in the concen-
trations required for activating the receptors suggests that
there are some fundamental differences in the structure of
the receptor compared to that found in mammalian systems
and that the natural ligand is not epinephrine but could possi-
bly be a metabolite of the catecholamines.
In the antagonist experiments our findings demon-
strated that the aAR antagonist phentolamine had no
effect on epinephrine-mediated encystment which
supports the earlier observation that aAR agonists did not
enhance the encystment process. The bAR antagonists
alprenolol and propranolol both caused a reduction in the
level of encystment of around 30% with the specific bAR1
antagonist metoprolol causing biggest decrease of > 55%.
The bAR2 antagonist gave a < 10% reduction in the
encystment levels which suggests that the bAR2 adreno-
ceptor is not involved in the encystment process. Com-
bined, the results indicate that selective bAR1 agonists
and antagonists can be used to promote and inhibit the
encystment process. Furthermore, in an unpublished
observation we have demonstrated that metoprolol can
completely inhibit natural encystment triggered by Neff’s
defined encystment medium (Neff et al. 1964) in all three
strains of Acanthamoeba used in this study.
These findings mirror that of a previous study with E. in-
vadens which also demonstrated that bAR1 agonists and
antagonists can be used to promote and inhibit the
encystment process. Using a radio-labelled nonselective
bAR agonist [3H]-CGP-12177, the authors were also able
to show that nonlabelled bAR antagonists including meto-
prolol could block the binding of [3H]-CGP-12177 and pre-
vent encystment in a dose-dependent manner (Coppi
et al. 2002). Other protozoa are believed to contain adren-
ergic signalling systems including the ciliate Tetrahymena
through its response to aAR and bAR agonists and antago-
nists (Blum 1967).
Studies with dibutyryl-cAMP a nonhydrolysable form of
cAMP which readily crosses cell membrane demonstrated
that it too promoted encystment. This combined with the
agonist and antagonist studies initially lead us to believe
that the receptor was similar to the mammalian bAR1
adrenoceptor. In the human body bAR1 is known to be pri-
marily coupled to the Gs protein which activates adenylate
cyclase leading to the intracellular accumulation of cAMP
and the subsequent activation protein kinase A (Harmar
et al. 2009). During normal amoebic growth intracellular
cAMP levels are constant in the Acanthamoeba tropho-
zoite but increase when the trophozoite encysts (Gessat
and Jantzen 1974; Neff and Neff 1969). In mammalian
systems cAMP is broken down to 50 monophosphate by
the enzyme phosphodiesterase (PDE) (Butcher and
Sutherland 1962) and studies have shown that PDE inhibi-
tors like theophylline can increase the level of encystment
in A. culbertsoni (Verma et al. 1974).
However, although the results suggest the involvement
of a bAR1 receptor a search of the recently sequenced
Acanthamoeba genome indicates that there are no
sequences that share homology with known mammalian
adrenergic receptor systems present. Therefore, further
studies will be required to determine the structure of the
receptor that the bAR1 agonists and antagonists are inter-
acting with. Interestingly the Acanthamoeba genome has
revealed that they encode thirty-five G-protein-coupled
receptors involved in cell signalling (Clarke et al. 2013)
and so the authors believe that an as yet unidentified
receptor is involved in adrenergic signalling in Acan-
thamoeba.
Table 3. The effect of the catecholamine synthesis inhibitor a-
methyl-p-tyrosine (AMPT) on the encystment of Acanthamoeba poly-
phaga
Time
% Encystment (SEM)
GM GM + AMPT
Day 2 20.6  0.2 8.0  1.6
Day 4 31.8  1.8 9.4  1.1
Day 7 64.8  3.9 18.2  1.1
aThe values reported are  the standard error of the mean from tripli-
cate experiments.
bGM (Growth media).
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Magnesium Chloride (MgCl2) was also present in the
encystment medium and appears to play some role in medi-
ating the encystment process, as when present there was
a three fold increase in encystment compared to the con-
trol. One possibility for the encystment promoting activity
of Mg2+ lies in its ability to increase the fluidity of the lipid
bilayer by interacting with negatively charged phospholipids
leading to the modification in activity of membrane bound
enzymes (Fuyu et al. 1983). Previous authors have demon-
strated that bAR stimulation in cardiac and liver cells results
an increase in levels of cAMP and a concomitant release of
Mg2+ (Romani et al. 1991). Probably one of the most signifi-
cant processes that has been shown to occur during the
encystment of Acanthamoeba is the breakdown of intracel-
lular glycogens store (Weisman et al. 1970). In this process
glycogen is degraded to glucose-1-phosphate by the
enzyme glycogen phosphorylase (Heilmeyer 1991). The
resulting glucose is then polymerized to form the cellulose
cyst wall (Neff and Neff 1969). Divalent metal ions including
Mg2+ have been demonstrated to increase the affinity of
phosphorylase kinase for glycogen phosphorylase resulting
in enzyme activation (Xu et al. 1996). Therefore, this may
explain how the presence of Mg2+ in the medium promotes
the encystment process by increasing the liberation of glu-
cose from glycogen making more sugar available for cyst
wall synthesis.
Synthesis of catecholamines like epinephrine occurs
through a stepped synthesis pathway directly from the
amino acid tyrosine or indirectly from phenylalanine. The
rate limiting step in this pathway involves the conversion
of tyrosine to DOPA by the enzyme tyrosine hydroxylase
(Nagatsu et al. 1964). Assuming that Acanthamoeba have
a catecholamine synthesis pathway, we incubated tropho-
zoites with a catecholamine synthesis inhibitor to see if
there was any effect on the encystment process. This
study showed that 10 mM AMPT could competitively inhi-
bit the enzyme tyrosine hydroxylase by competing with
the free tyrosine in the medium (0.55 mM). This lead to a
reduction in the encystment of A. polyphaga of approxi-
mately 40% compared to the control after 7 d in an
encystment medium. Therefore, the results from this
study indicate that Acanthamoeba spp. can synthesize and
store catecholamines which are released to initiate encyst-
ment. This finding is supported by a previous study with
the ciliate T. pyriformis4 and the flagellate Crithidia fasicu-
lata which showed radiolabelled 14C-Tyrosine, 14C-Phenyla-
lanine amino acids became incorporated into the
catecholamines in these organisms (Janakidevi et al.
1966).
In conclusion, the findings of this study suggest that
Acanthamoeba spp. contain a functional adrenergic recep-
tor system of unknown structure that can be activated
and blocked by exogenous bAR1 agonists and antagonists.
In addition, the use of a catecholamine synthesis inhibitor
this study demonstrates that Acanthamoeba synthesize
and store catecholamines which are believed to be
released to trigger the encystment process. Acan-
thamoeba have been shown to encyst in vivo during infec-
tion (Clarke et al. 2005), however, the exact reason for
this unknown but it is possible they do this in response to
catecholamines present in the patients circulatory system
or contained within the lachrymal fluid.
The encysted form of Acanthamoeba is highly resistant
to kill using topical antimicrobial agents and so it may be
possible to use topical bAR antagonists as an adjunct ther-
apy in Acanthamoeba keratitis alongside the current drug
regime to reduce encystment of amoebae during treat-
ment. Preventing encystment could potentially enhance
treatment as the trophozoite is more susceptible to kill
using topical antimicrobial agents. It is hoped that this
approach could bring down the mean treatment time and
prevent recrudescence of infection. Topical bAR antago-
nists are well tolerated in the eye and are currently used
in the management of glaucoma (Ong et al. 2005).
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